Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Connect Biopharma Holdings Limited Sponsored ADR (CNTB : NSDQ)

• Company Description    Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research. The company's product candidate includes CBP-201. Connect Biopharma Holdings Limited is based in TAICANG, China. Number of Employees: 62

• Price / Volume Information    Yesterday's Closing Price: $2.82 Daily Weekly Monthly 20 Day Moving Average: 123,773 shares Shares Outstanding: 55.90 (millions) Market Capitalization: $157.65 (millions) Beta: -0.19 52 Week High: $3.28 52 Week Low: $0.51 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 11.02% 11.21% 12 Week 42.42% 40.13% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3580 CARMEL MOUNTAIN ROAD SUITE 200 - SAN DIEGO,CA 92130 USA ph: 877-245-2787 fax: +1 8586147007 dszekeres@connectpharm.com http://www.connectbiopharm.com

• General Corporate Information    Officers Barry D. Quart - Chief Executive Officer and Director Kleanthis G. Xanthopoulos - Chairman Lisa Peraza - Vice President; Finance Kan Chen - Director James Z. Huang - Director Peer Information Connect Biopharma Holdings Limited Sponsored ADR (CORR.) Connect Biopharma Holdings Limited Sponsored ADR (RSPI) Connect Biopharma Holdings Limited Sponsored ADR (CGXP) Connect Biopharma Holdings Limited Sponsored ADR (BGEN) Connect Biopharma Holdings Limited Sponsored ADR (GTBP) Connect Biopharma Holdings Limited Sponsored ADR (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G23549101 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 55.90 Most Recent Split Date: (:1) Beta: -0.19 Market Capitalization: $157.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.30 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.84 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.85 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -34.78% Sales Growth vs. Year Ago Period: -98.69% vs. Previous Quarter: -66.67% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - - 06/30/25 - - Current Ratio 12/31/25 - - 09/30/25 - 5.48 06/30/25 - 7.24 Quick Ratio 12/31/25 - - 09/30/25 - 5.48 06/30/25 - 7.24 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - 0.99 06/30/25 - 1.28 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.01 06/30/25 - 0.01 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.80 06/30/25 - 0.72

Powered by Zacks Investment Research ©